Overall, our findings illustrated that Calebin A significantly suppressed NF-κB activation and NF-κB-promoted anti-apoptotic biomarkers, making it a potentially effective inhibitor of inflammation, proliferation, invasion, and survival of cancer cells. Here, NFKB1 is linked to cancer.